ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.

July 11, 2008

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

NCI CTEP Approved Trials For the Month of March

March 29, 2013

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

Importation Is Remedy of Last Resort in Effort to Obtain Generic Injectables

March 2, 2012